Work

In current smokers with COPD, LABA+LAMA is superior to LABA+ICS, regardless of blood eosinophils. Data from the FLAME trial.

Year: 2024

Type: conference-paper

DOI: 10.1183/13993003.congress-2024.pa2992

Authors: Alexander Mathioudakis, Andrew Higham, Sebastian Bate, Victoria Chatzimavridou-Grigoriadou, Pradeesh Sivapalan, Jens-Ulrik Jensen, Tim Felton, Jørgen Vestbo, Dave Singh

Institutions: University of Manchester, Manchester University NHS Foundation Trust, Medicines Evaluation Unit, The Christie NHS Foundation Trust, University of Copenhagen, Copenhagen University Hospital, Gentofte Hospital

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404099334

FWCI:

Cites:

Cited by:

Related to: 10